In breast cancer cell lines, AQP5 knockdown increased the MAPK signal transduction pathway, decreasing cell invasion and metastasis and growth while enhancing chemosensitivity, indicating that AQP5 could be advantageous as a predictive biomarker and therapeutic target [168, 169]. Here, AQP5 is linked to breast cancer.